Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase III Study of Surufatinib in Treating Advanced Extrapancreatic Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02588170
Recruitment Status : Active, not recruiting
First Posted : October 27, 2015
Last Update Posted : April 15, 2021
Sponsor:
Information provided by (Responsible Party):
Hutchison Medipharma Limited